|
1
|
de Latour RP, Mary JY, Salanoubat C,
Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn
JY and Socié G: French Society of Hematology; French Association of
Young Hematologists: Paroxysmal nocturnal hemoglobinuria: Natural
history of disease subcategories. Blood. 112:3099–3106. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Latour Peffault R, Amoura Z and Socié
G: Paroxysmal nocturnal hemoglobinuria. Rev Med Interne.
31:200–207. 2010.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kinoshita T and Inoue N: Relationship
between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Int J Hematol. 75:117–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang D, Fu R, Ruan EB, Qu W, Liang Y, Wang
HQ, Wang J, Li LJ, Liu H, Wang HL, et al: EPOR and TPOR expressions
on CD34+ CD59− and CD34+
CD59+ bone marrow cells from patients with paroxysmal
nocturnal hemoglobinuria. Zhonghua Xue Ye Xue Za Zhi. 32:543–547.
2011.(In Chinese). PubMed/NCBI
|
|
5
|
Wang D, Fu R, Ruan EB, Qu W, Liang Y, Wang
HQ, Wang J, Li LJ, Liu H, Wang HL, et al: STAT5 phosphorylation
levels of erythropoietin and thrombopoietin receptors in
CD34(+)CD59(−) and CD34(+) CD59(+) bone marrow cells of patients
with paroxysmal nocturnal hemoglobinuria. Zhonghua Yi Xue Za Zhi.
91:2129–2131. 2011.(In Chinese). PubMed/NCBI
|
|
6
|
Borowitz MJ, Craig FE, Digiuseppe JA,
Illingworth AJ, Rosse W, Sutherland DR, Wittwer CT and Richards SJ:
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal
hemoglobinuria and related disorders by flow cytometry. Cytometry B
Clin Cytom. 78:211–230. 2010.PubMed/NCBI
|
|
7
|
Raza A, Ravandi F, Rastogi A, Bubis J, Lim
SH, Weitz I, Castro-Malaspina H, Galili N, Jawde RA and Illingworth
A: A prospective multicenter study of paroxysmal nocturnal
hemoglobinuria cells in patients with bone marrow failure.
Cytometry B Clin Cytom. 86:175–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arruda MM, Rodrigues CA, Yamamoto M and
Figueiredo MS: Paroxysmal nocturnal hemoglobinuria: From
physiopathology to treatment. Rev Assoc Med Bras. 56:214–221.
2010.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brodsky RA: How I treat paroxysmal
nocturnal hemoglobinuria. Blood. 113:6522–6527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raiola AM, Van Lint MT, Lamparelli T,
Gualandi F, Benvenuto F, Figari O, Mordini N, Berisso G, Bregante
S, Frassoni F and Bacigalupo A: Bone marrow transplantation for
paroxysmal nocturnal hemoglobinuria. Haematologica. 85:59–62.
2000.PubMed/NCBI
|
|
11
|
Röth A and Dührsen U: Treatment of
paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Eur J
Haematol. 87:473–479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Charneski L and Patel PN: Eculizumab in
paroxysmal nocturnal haemoglobinuria. Drugs. 68:1341–1346. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindorfer MA, Pawluczkowycz AW, Peek EM,
Hickman K, Taylor RP and Parker CJ: A novel approach to preventing
the hemolysis of paroxysmal nocturnal hemoglobinuria: Both
complement-mediated cytolysis and C3 deposition are blocked by a
monoclonal antibody specific for the alternative pathway of
complement. Blood. 115:2283–2291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scholz M, Schirm S, Wetzler M, Engel C and
Loeffler M: Pharmacokinetic and -dynamic modelling of G-CSF
derivatives in humans. Theor Biol Med Model. 9:322012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liongue C, Wright C, Russell AP and Ward
AC: Granulocyte colony-stimulating factor receptor: Stimulating
granulopoiesis and much more. Int J Biochem Cell Biol.
41:2372–2375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marino VJ and Roguin LP: The granulocyte
colony stimulating factor (G-CSF) activates Jak/STAT and MAPK
pathways in a trophoblastic cell line. J Cell Biochem.
103:1512–1523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ward AC, Gits J, Majeed F, Aprikyan AA,
Lewis RS, O'Sullivan LA, Freedman M, Shigdar S, Touw IP, Dale DC
and Dror Y: Functional interaction between mutations in the
granulocyte colony-stimulating factor receptor in severe congenital
neutropenia. Br J Haematol. 142:653–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roskoski R Jr: Structure and regulation of
Kit protein-tyrosine kinase - The stem cell factor receptor.
Biochem Biophys Res Commun. 338:1307–1315. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Zhang R, Joachimiak A,
Schlessinger J and Kong XP: Crystal structure of human stem cell
factor: Implication for stem cell factor receptor dimerization and
activation. Proc Natl Acad Sci USA. 97:7732–7737. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brizzi MF, Dentelli P, Rosso A, Yarden Y
and Pegoraro L: STAT protein recruitment and activation in c-Kit
deletion mutants. J Biol Chem. 274:16965–16972. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao YR, Shao ZH, Liu H, Shi J, Bai J, Tu
MF, Wang HQ, Xing LM, Cui ZZ, Sun J, et al: The response of bone
marrow hematopoietic cells to G-CSF in paroxysmal nocturnal
hemoglobinuria patients. Zhonghua Xue Ye Xue Za Zhi. 26:235–238.
2005.(In Chinese). PubMed/NCBI
|
|
22
|
Savage WJ, Barber JP, Mukhina GL, Hu R,
Chen G, Matsui W, Thoburn C, Hess AD, Cheng L, Jones RJ and Brodsky
RA: Glycosylphosphatidylinositol-anchored protein deficiency
confers resistance to apoptosis in PNH. Exp Hematol. 37:42–51.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao YR, Shao ZH, Liu H, Zhao MF, He GS,
Shi J, Bai J, Fu R, Tu MF, Wang HQ, et al: Expression of
apoptosis-related proteins in bone marrow neutrophils of patients
with paroxysmal nocturnal hemoglobinuria. Zhongguo Shi Yan Xue Ye
Xue Za Zhi. 13:871–874. 2005.(In Chinese). PubMed/NCBI
|
